Back
Phathom Pharmaceuticals Vs. Oramed Pharmaceuticals Industry Stock Comparison
Buy
90
PHAT
Phathom Pharmaceuticals
Last Price:
10.63
Seasonality Move:
29.55%
Sell
42
ORMP
Oramed Pharmaceuticals
Last Price:
2.93
Seasonality Move:
20.33%
Buy
90
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.61. The Score for PHAT is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
42
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.92. The Score for ORMP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ORMP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORMP is experiencing slight selling pressure.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 60.74 | Buy |
Chaikin Money Flow: | -419640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.56 - 10.66) | Buy |
Bollinger Bands (100): | (7.09 - 9.55) | Buy |
ORMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 50.42 | Buy |
Chaikin Money Flow: | -45917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.75 - 3.29) | Sell |
Bollinger Bands (100): | (2.11 - 2.99) | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.07 | Buy |
20-day SMA: | 9.41 | Buy |
50-day SMA: | 8.53 | Buy |
200-day SMA: | 10.46 | Buy |
8-day EMA: | 10.17 | Buy |
20-day EMA: | 9.58 | Buy |
50-day EMA: | 9.01 | Buy |
200-day EMA: | 9.64 | Buy |
ORMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.84 | Buy |
20-day SMA: | 2.92 | Buy |
50-day SMA: | 2.89 | Buy |
200-day SMA: | 2.76 | Buy |
8-day EMA: | 2.85 | Buy |
20-day EMA: | 2.9 | Buy |
50-day EMA: | 2.85 | Buy |
200-day EMA: | 2.98 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.58 per share, and an increase next year of $1.24 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oramed Pharmaceuticals Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |